The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J04 | Antimycobacterials | |
| 3 | J04A | Drugs for treatment of tuberculosis | |
| 4 | J04AK | Other drugs for treatment of tuberculosis | |
| 5 | J04AK02 | Ethambutol |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 1.2 g |
| PAREN - Parenteral | 1.2 g |
| Active Ingredient | Description | |
|---|---|---|
| Ethambutol |
Ethambutol is bacteriostatic. It is effective against Mycobacterium tuberculosi and M.bovis with an MIC of 0.5–8µg per ml. The exact mechanism of action is unknown. While it has activity against some atypical mycobacteria including M.Kansasii, activity against other micro-organisms has not yet been reported. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ETIBI Tablet | Health Products and Food Branch (CA) | MPI, CA: SPM | |
| MYAMBUTOL Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
